Kintara Therapeutics Inc. Recorded Big Gain
Wed, Jan 17, 2024 at 07:12 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) soared at $0.16, a gain of 24.5%. On Wed, Jan 17, 2024, KTRA:NASDAQ touched a New 2-Week Intraday High of $0.17. From Wed, Jan 03, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Fri, Dec 29, 2023 at $0.3 with a volume of 123M+.
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Airspan Networks Holdings Inc. (MIMO:NYSEMKT), 186.09%
- Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ), 77.5%
- Fitell Corporation (FTEL:NASDAQ), 36.36%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 32.65%
- LQR House Inc. (LQR:NASDAQ), 31.68%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 30.71%
- Safety Shot Inc Com (SHOT:NASDAQ), 29.61%
- Aurora Technology Acquisition Corp. (ATAK:NASDAQ), 28.1%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 24.51%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 23.08%